An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)
PHASE3CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
October 31, 2004
Primary Completion Date
September 30, 2005
Study Completion Date
October 31, 2005
Conditions
Lipid Metabolism, Inborn ErrorsHeart Disease
Interventions
DRUG
MK0653, ezetimibe
DRUG
Comparator: placebo
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00092898 - An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) | Biotech Hunter | Biotech Hunter